Complementation Between Urokinase-producing and Receptor-producing Cells in Extracellular Matrix Degradation
Overview
Cell Biology
Molecular Biology
Affiliations
The respective roles of urokinase plasminogen activator (u-PA) and the u-PA receptor in extracellular matrix degradation was investigated. Human pro-u-PA and the human u-PA receptor were expressed independently by two different mouse LB6 cell lines. The matrix degradation capacity of these cell lines individually or in coculture was studied. Although pro-u-PA-producing cells alone degrade the matrix in the presence of plasminogen, u-PA-receptor producing cells do not. Cocultivation of a small fraction of pro-u-PA-producing cells with the receptor-producing cells increases the rate of matrix degradation at least threefold. By immunoprecipitation it was shown that cocultivation of the two cell lines increases the conversion of the inactive pro-u-PA to the active two chain u-PA. The enhancement of matrix degradation and of pro-u-PA activation requires actual binding of pro-u-PA to its receptor because it is inhibited by u-PA-receptor antagonists. The u-PA receptor must be cell associated, as binding of pro-u-PA to a receptor solubilized from the cell surface with phosphatidyl-inositol specific phospholipase C did not enhance the activation of pro-u-PA in the presence of plasminogen. The finding that activity of u-PA is enhanced when it is bound to its receptor, even when the receptor is produced by a different cell, might have important implications for the mechanisms of u-PA-induced extracellular proteolysis in vivo.
Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy.
Li D, Liu S, Shan H, Conti P, Li Z Theranostics. 2013; 3(7):507-15.
PMID: 23843898 PMC: 3706694. DOI: 10.7150/thno.5557.
The effect of suramin on the resorption of bovine nasal cartilage.
Lewis C, Frazer A, Russell R, Bunning R Inflammopharmacology. 2007; 7(4):387-400.
PMID: 17657441 DOI: 10.1007/s10787-999-0032-x.
Lee K, Hyun M, Kim J Clin Exp Metastasis. 2003; 20(6):499-505.
PMID: 14598883 DOI: 10.1023/a:1025824816021.
Bryson H, Buttle D, Kozaci L, Johnatty R, Bunning R Biochem J. 2000; 345 Pt 3:495-501.
PMID: 10642507 PMC: 1220783.
Harvey S, Sait S, Xu Y, Bailey J, Penetrante R, Markus G Am J Pathol. 1999; 155(4):1115-20.
PMID: 10514394 PMC: 1867004. DOI: 10.1016/S0002-9440(10)65214-5.